NOI Luminex Triplex Assay

Closed Pre-Solicitation Posted

Solicitation number
NOI_230
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
30341, United States

Notice details come from SAM.gov. Updated .

About this opportunity

Paragraph 1:

The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price purchase order to Luminex Technology for the scale up production of a triplex assay. This contract action is being issued under the authority of FAR 13.106-1(b) for supplies or services for which the Government intends to solicit and negotiate with only one source. Interested parties may identify their interest and capability to respond to the requirement or submit proposals, which will be considered by the government. The quotations/responses should be submitted via email to the contract specialist by July 25, 2024 at 11:00 AM EST.

Paragraph 2:

This contract opportunity is not set aside for any specific business type. Luminex Technology, located at 12212 Technology Blvd, Austin, Texas 78727, is the only known source capable of providing the required triplex assay. The government will make a determination, based on the responses received, whether to conduct a competitive procurement. No specific award value or budget range is provided in the notice.

Notice text

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Luminex Technology (dba 12212 Technology Blvd, Austin Texas 78727). Luminex is the only company which can provide the scale up production of the triplex assay. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations / responses received within 5 days of the issuance of this notice will be considered by the government.  A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.  Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.  Any quotation/response should be emailed to contract specialist at Abbie Jemmott ygf3@cdc.gov by 7/25/2024 @ 11:00 AM EST. 

Similar open opportunities

Opportunity Agency Set-aside Responses due
Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical Center Bethesda, Maryland 20892, United States · NAICS 334516 National Institutes of Health No set-aside
Notice of Intent to Sole Source a Thermo Orbitrap Fusion Lumos and Thermo RSLCnano UPLC Maintenance Agreement Georgia 30329, United States · NAICS 811210 CDC Office of Acquisition Services No set-aside
NOI - A Non-Invasive Prognostic Biomarker NAICS 541714 Office of Logisitics and Acquisition Operations No set-aside
Intent to Sole Source - BD FACSCanto II instrument Bethesda, Maryland 20892, United States · NAICS 334516 National Institutes of Health No set-aside
Notice of Intent: Measuring AAV9 vector DNA in mice tissue using qPCR Bethesda, Maryland 20892, United States · NAICS 541380 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity